在注射感染CRF01_AE的药物的人群中频繁检测混合核心受体使用的HIV-1变体:可能与核心受体开关有关.
Yosuke Maeda1,2, Takayuki Chikata3,4, Takeo Kuwata3
1Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Open forum infectious diseases
|March 4, 2026
概括
人类免疫缺陷病毒1型 (HIV-1) 混合感染,涉及不同的核心受体使用,在36.1%的注射药物使用者 (PWID) 中发现. 这种混合感染可能与核心受体切换和更高的病毒载荷有关.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 以前的研究表明,混合R5和X4/双HIV-1感染可能导致核心受体切换.
- 这项研究旨在在感染CRF01_AE亚型的注射毒品者 (PWID) 中证实这一假设.
研究的目的:
- 调查PWID中不同核心受体使用混合HIV-1感染的患病率和特征.
- 探索混合感染,核心受体开关和血病毒RNA负载 (pVL) 之间的关联.
主要方法:
- 来自PWID的病毒血RNA的深度测序.
- 对HIV-1 gp120 V3基因的放大和测序.
- 表型分析和基于序列的预测,以确定病毒变异的核心受体使用情况.
主要成果:
- 在研究的PWID中,在36.1%的PWID中发现了具有明显的核心受体使用的混合HIV-1感染.
- R5变种通常占主导地位,X4/双变种作为小种群,但有一例显示相反.
- 与R5-only感染相比,混合R5和X4/双HIV-1感染的病例中观察到较高的血病毒RNA负载 (pVL).
结论:
- 混合的HIV-1核受体使用可能与CRF01_AE感染PWID的核受体切换有关.
- 混合HIV-1感染似乎与血病毒RNA负载 (pVL) 的增加相关.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


